3 Dirt Cheap Stocks to Buy Right Now
By most metrics, the stock market is priced at a premium these days. But that doesn't mean bargains can't still be found.
Three Motley Fool contributors think they've identified dirt-cheap healthcare stocks to buy right now. Here's why they picked CRISPR Therapeutics (NASDAQ: CRSP), Gilead Sciences (NASDAQ: GILD), and (NYSE: PFE).
Prosper Junior Bakiny (CRISPR Therapeutics): Valuing relatively small biotech companies that generate little-to-no revenue is not an exact science. Even so, CRISPR Therapeutics, a gene-editing specialist, looks cheap at its current levels. CRISPR Therapeutics' market cap is $4.2 billion despite the recent approval of Casgevy, a treatment for two blood-related diseases it developed in collaboration with Vertex Pharmaceuticals.
Source Fool.com
Pfizer Inc. Stock
The stock is one of the favorites of our community with 30 Buy predictions and 4 Sell predictions.
As a result the target price of 40 € shows a very positive potential of 53.29% compared to the current price of 26.1 € for Pfizer Inc..
